Eric S. Fischer

13.8k total citations · 6 hit papers
118 papers, 6.7k citations indexed

About

Eric S. Fischer is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Eric S. Fischer has authored 118 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Molecular Biology, 27 papers in Oncology and 17 papers in Hematology. Recurrent topics in Eric S. Fischer's work include Protein Degradation and Inhibitors (79 papers), Ubiquitin and proteasome pathways (63 papers) and Peptidase Inhibition and Analysis (18 papers). Eric S. Fischer is often cited by papers focused on Protein Degradation and Inhibitors (79 papers), Ubiquitin and proteasome pathways (63 papers) and Peptidase Inhibition and Analysis (18 papers). Eric S. Fischer collaborates with scholars based in United States, Switzerland and Germany. Eric S. Fischer's co-authors include Katherine A. Donovan, Nathanael S. Gray, Radosław P. Nowak, Nicolas H. Thomä, Tinghu Zhang, Georg Petzold, Benjamin L. Ebert, Baishan Jiang, Eric S. Wang and James E. Bradner and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Eric S. Fischer

111 papers receiving 6.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Plasticity in binding confers selectivity in ligand-induced protein degradation

2018 427 citations Radosław P. Nowak, Zhixiang He et al. Nature Chemical Biology profile →
Structural basis of lenalidomide-induced CK1α degradation by the CRL4CRBN ubiquitin ligase

2016 418 citations Georg Petzold, Eric S. Fischer et al. profile →
Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation

2017 402 citations Baishan Jiang, Michael A. Erb et al. Nature Chemical Biology profile →
A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader

2017 330 citations Hai‐Tsang Huang, Zainab M. Doctor et al. profile →
Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome

2018 312 citations Katherine A. Donovan, Radosław P. Nowak et al. eLife profile →
Targeted protein degradation: from mechanisms to clinic

2024 146 citations Radosław P. Nowak, Benjamin L. Ebert et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric S. Fischer United States	37	6.0k	2.3k	1.3k	437	339	118	6.7k
James E. Bradner United States	28	3.6k 0.6×	1.3k 0.6×	792 0.6×	400 0.9×	186 0.5×	63	4.5k
Joel Johansson United States	34	4.3k 0.7×	1.8k 0.8×	1.1k 0.9×	739 1.7×	275 0.8×	93	6.0k
Warren Fiskus United States	48	5.1k 0.9×	1.2k 0.5×	1.7k 1.3×	511 1.2×	194 0.6×	141	6.3k
David J. Bearss United States	34	4.9k 0.8×	1.5k 0.6×	457 0.4×	657 1.5×	306 0.9×	114	6.5k
Junwei Shi United States	35	6.2k 1.0×	1.3k 0.6×	1.5k 1.1×	513 1.2×	88 0.3×	105	7.3k
Mark Rolfe United States	31	4.6k 0.8×	2.5k 1.1×	471 0.4×	407 0.9×	160 0.5×	55	6.0k
Roy M. Pollock United States	29	5.4k 0.9×	636 0.3×	958 0.7×	385 0.9×	214 0.6×	55	6.4k
Christin Tse United States	22	3.5k 0.6×	882 0.4×	375 0.3×	415 0.9×	250 0.7×	24	4.3k
Laura Soucek Spain	32	3.7k 0.6×	1.7k 0.8×	225 0.2×	855 2.0×	168 0.5×	54	5.0k
Tomasz Skórski United States	46	3.8k 0.6×	1.7k 0.7×	3.1k 2.4×	518 1.2×	276 0.8×	175	6.8k

Countries citing papers authored by Eric S. Fischer

Since Specialization

Citations

This map shows the geographic impact of Eric S. Fischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric S. Fischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric S. Fischer more than expected).

Fields of papers citing papers by Eric S. Fischer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric S. Fischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric S. Fischer. The network helps show where Eric S. Fischer may publish in the future.

Co-authorship network of co-authors of Eric S. Fischer

This figure shows the co-authorship network connecting the top 25 collaborators of Eric S. Fischer. A scholar is included among the top collaborators of Eric S. Fischer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric S. Fischer. Eric S. Fischer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhuang, Zhe, Woong Sub Byun, Zuzanna Kozicka, et al.. (2025). Development of FBXO22 Degraders and the Recruitment Ligand 2-Pyridinecarboxyaldehyde (2-PCA). Journal of the American Chemical Society. 147(49). 45132–45144.

Baek, Kheewoong, Shourya S. Roy Burman, Jonathan W. Bushman, et al.. (2025). Unveiling the hidden interactome of CRBN molecular glues. Nature Communications. 16(1). 6831–6831. 11 indexed citations

Hassan, Muhammad Murtaza, Yen-Der Li, W Michelle, et al.. (2024). Exploration of the tunability of BRD4 degradation by DCAF16 trans-labelling covalent glues. European Journal of Medicinal Chemistry. 279. 116904–116904. 12 indexed citations

Liu, Han‐Yuan, Zhixiang He, Inchul You, et al.. (2024). Discovery of Potent Degraders of the Dengue Virus Envelope Protein. Advanced Science. 11(40). e2405829–e2405829. 4 indexed citations

Hulsman, Marc, Katherine A. Donovan, Eric S. Fischer, et al.. (2024). SMAC mimetics induce human macrophages to phagocytose live cancer cells. PubMed. 5(1). ltaf026–ltaf026.

Huang, Hai‐Tsang, Ryan J. Lumpkin, Xu Zhao, et al.. (2024). Ubiquitin-specific proximity labeling for the identification of E3 ligase substrates. Nature Chemical Biology. 20(9). 1227–1236. 26 indexed citations

Liu, Han‐Yuan, Zhengnian Li, Zhixiang He, et al.. (2024). Broad-spectrum activity against mosquito-borne flaviviruses achieved by a targeted protein degradation mechanism. Nature Communications. 15(1). 5179–5179. 11 indexed citations

Wachter, Franziska, Radosław P. Nowak, Scott B. Ficarro, Jarrod A. Marto, & Eric S. Fischer. (2024). Structural characterization of methylation-independent PP2A assembly guides alphafold2Multimer prediction of family-wide PP2A complexes. Journal of Biological Chemistry. 300(5). 107268–107268. 2 indexed citations

Teng, Mingxing, Jie Jiang, Eric S. Wang, et al.. (2023). Targeting the Dark Lipid Kinase PIP4K2C with a Potent and Selective Binder and Degrader. Angewandte Chemie. 135(18).

10.

Kozicka, Zuzanna, Dakota J. Suchyta, Georg Kempf, et al.. (2023). Design principles for cyclin K molecular glue degraders. Nature Chemical Biology. 20(1). 93–102. 54 indexed citations

11.

Doctor, Zainab M., Annan Yang, Mingfeng Hao, et al.. (2023). Development and Characterization of Selective FAK Inhibitors and PROTACs with In Vivo Activity. ChemBioChem. 24(19). e202300141–e202300141. 8 indexed citations

12.

Nguyen, Tuan M., Vedagopuram Sreekanth, Arghya Deb, et al.. (2023). Proteolysis-targeting chimeras with reduced off-targets. Nature Chemistry. 16(2). 218–228. 67 indexed citations

13.

Meyerhardt, Jeffrey A., Hong Yue, Radosław P. Nowak, et al.. (2022). Serological testing for SARS-CoV-2 antibodies of employees shows low transmission working in a cancer center. PLoS ONE. 17(4). e0266791–e0266791.

14.

Koochaki, Sebastian, Mikołaj Słabicki, Ryan J. Lumpkin, et al.. (2022). A STUB1 ubiquitin ligase/CHIC2 protein complex negatively regulates the IL-3, IL-5, and GM-CSF cytokine receptor common β chain (CSF2RB) protein stability. Journal of Biological Chemistry. 298(10). 102484–102484. 4 indexed citations

15.

Zhang, Wubing, Shourya S. Roy Burman, Jiaye Chen, et al.. (2022). Machine Learning Modeling of Protein-Intrinsic Features Predicts Tractability of Targeted Protein Degradation. Genomics Proteomics & Bioinformatics. 20(5). 882–898. 26 indexed citations

16.

Teng, Mingxing, Wenchao Lu, Katherine A. Donovan, et al.. (2021). Development of PDE6D and CK1α Degraders through Chemical Derivatization of FPFT-2216. Journal of Medicinal Chemistry. 65(1). 747–756. 34 indexed citations

17.

Dubey, Abhinav, Thibault Viennet, Sandeep Chhabra, et al.. (2021). Local Deuteration Enables NMR Observation of Methyl Groups in Proteins from Eukaryotic and Cell‐Free Expression Systems. Angewandte Chemie International Edition. 60(25). 13783–13787. 9 indexed citations

18.

Ryu, SeongShick, Benjamin Fram, Jie Jiang, et al.. (2021). Synthesis and structure-activity relationships of targeted protein degraders for the understudied kinase NEK9. SHILAP Revista de lepidopterología. 1. 100008–100008. 2 indexed citations

19.

Silva, M. Catarina, Fleur M. Ferguson, Quan-Ying Cai, et al.. (2019). Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models. eLife. 8. 203 indexed citations

20.

Jiang, Baishan, Michael A. Erb, Yanke Liang, et al.. (2017). Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation. DSpace@MIT (Massachusetts Institute of Technology). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact